Cargando…

Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study

OBJECTIVE: Fibroblast activation protein (FAP)-targeting radiopharmaceutical based on the FAP-specific inhibitor (FAPI) is considered as a potential alternative agent to FDG for tumor-specific imaging. However, FAP is also expressed in normal adult tissues. The aim of this study was to explore the i...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Na, Wang, Hao, Wang, Haiyan, Ren, Shuhua, You, Zhiwen, Chen, Xing, Guan, Yihui, Xie, Fang, Hua, Fengchun, Zhao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751966/
https://www.ncbi.nlm.nih.gov/pubmed/36531015
http://dx.doi.org/10.3389/fonc.2022.989595
_version_ 1784850602622189568
author Qi, Na
Wang, Hao
Wang, Haiyan
Ren, Shuhua
You, Zhiwen
Chen, Xing
Guan, Yihui
Xie, Fang
Hua, Fengchun
Zhao, Jun
author_facet Qi, Na
Wang, Hao
Wang, Haiyan
Ren, Shuhua
You, Zhiwen
Chen, Xing
Guan, Yihui
Xie, Fang
Hua, Fengchun
Zhao, Jun
author_sort Qi, Na
collection PubMed
description OBJECTIVE: Fibroblast activation protein (FAP)-targeting radiopharmaceutical based on the FAP-specific inhibitor (FAPI) is considered as a potential alternative agent to FDG for tumor-specific imaging. However, FAP is also expressed in normal adult tissues. The aim of this study was to explore the image features of non-tumoral regions with high uptake of (68)Ga-FAPI-04 in positron emission tomography (PET) imaging and to reveal the physiological mechanisms of these regions. MATERIAL: A total of 137 patients who underwent whole-body (68)Ga-FAPI-04 PET/MR (n=46) or PET/CT (n=91) were included in this retrospective study. Three experienced nuclear medicine physicians determined the non-tumoral regions according to other imaging modalities (CT, MRI, (18)F-FDG PET, or ultrasound), clinical information, or pathological results. The regions of interest (ROIs) were drawn manually, and the maximum standardized uptake value (SUV(max)) was measured. RESULTS: A total of 392 non-tumoral uptake regions were included in this study. The included physiological regions were uterus (n=38), submandibular gland (n=118), nipple (n=37), gingiva (n=65), and esophagus (n=31). The incidence of (68)Ga-FAPI-04 uptake in physiological regions was independent of age, the tracer uptakes in the gingiva and esophagus were more common in male patients (p=0.006, 0.009), while that in the nipple was more common in female patients (p < 0.001). The included benign regions were inflammatory lymph node (n =10), pneumonia (n=13), atherosclerosis (n=10), pancreatitis (n=18), osteosclerosis (n=45), and surgical scar (n=7). No significant difference was observed in SUV(max) between physiological and benign regions. CONCLUSIONS: A number of organs exhibit physiological uptakes of (68)Ga-FAPI-04. Our study showed that regions with high (68)Ga-FAPI-04 uptake did not necessarily represent malignancy. Being familiar with physiological and typical benign (68)Ga-FAPI-04 uptake regions can be helpful for physicians to interpret images and to make an accurate diagnosis.
format Online
Article
Text
id pubmed-9751966
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97519662022-12-16 Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study Qi, Na Wang, Hao Wang, Haiyan Ren, Shuhua You, Zhiwen Chen, Xing Guan, Yihui Xie, Fang Hua, Fengchun Zhao, Jun Front Oncol Oncology OBJECTIVE: Fibroblast activation protein (FAP)-targeting radiopharmaceutical based on the FAP-specific inhibitor (FAPI) is considered as a potential alternative agent to FDG for tumor-specific imaging. However, FAP is also expressed in normal adult tissues. The aim of this study was to explore the image features of non-tumoral regions with high uptake of (68)Ga-FAPI-04 in positron emission tomography (PET) imaging and to reveal the physiological mechanisms of these regions. MATERIAL: A total of 137 patients who underwent whole-body (68)Ga-FAPI-04 PET/MR (n=46) or PET/CT (n=91) were included in this retrospective study. Three experienced nuclear medicine physicians determined the non-tumoral regions according to other imaging modalities (CT, MRI, (18)F-FDG PET, or ultrasound), clinical information, or pathological results. The regions of interest (ROIs) were drawn manually, and the maximum standardized uptake value (SUV(max)) was measured. RESULTS: A total of 392 non-tumoral uptake regions were included in this study. The included physiological regions were uterus (n=38), submandibular gland (n=118), nipple (n=37), gingiva (n=65), and esophagus (n=31). The incidence of (68)Ga-FAPI-04 uptake in physiological regions was independent of age, the tracer uptakes in the gingiva and esophagus were more common in male patients (p=0.006, 0.009), while that in the nipple was more common in female patients (p < 0.001). The included benign regions were inflammatory lymph node (n =10), pneumonia (n=13), atherosclerosis (n=10), pancreatitis (n=18), osteosclerosis (n=45), and surgical scar (n=7). No significant difference was observed in SUV(max) between physiological and benign regions. CONCLUSIONS: A number of organs exhibit physiological uptakes of (68)Ga-FAPI-04. Our study showed that regions with high (68)Ga-FAPI-04 uptake did not necessarily represent malignancy. Being familiar with physiological and typical benign (68)Ga-FAPI-04 uptake regions can be helpful for physicians to interpret images and to make an accurate diagnosis. Frontiers Media S.A. 2022-12-01 /pmc/articles/PMC9751966/ /pubmed/36531015 http://dx.doi.org/10.3389/fonc.2022.989595 Text en Copyright © 2022 Qi, Wang, Wang, Ren, You, Chen, Guan, Xie, Hua and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Qi, Na
Wang, Hao
Wang, Haiyan
Ren, Shuhua
You, Zhiwen
Chen, Xing
Guan, Yihui
Xie, Fang
Hua, Fengchun
Zhao, Jun
Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study
title Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study
title_full Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study
title_fullStr Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study
title_full_unstemmed Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study
title_short Non-tumoral uptake of (68)Ga-FAPI-04 PET: A retrospective study
title_sort non-tumoral uptake of (68)ga-fapi-04 pet: a retrospective study
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751966/
https://www.ncbi.nlm.nih.gov/pubmed/36531015
http://dx.doi.org/10.3389/fonc.2022.989595
work_keys_str_mv AT qina nontumoraluptakeof68gafapi04petaretrospectivestudy
AT wanghao nontumoraluptakeof68gafapi04petaretrospectivestudy
AT wanghaiyan nontumoraluptakeof68gafapi04petaretrospectivestudy
AT renshuhua nontumoraluptakeof68gafapi04petaretrospectivestudy
AT youzhiwen nontumoraluptakeof68gafapi04petaretrospectivestudy
AT chenxing nontumoraluptakeof68gafapi04petaretrospectivestudy
AT guanyihui nontumoraluptakeof68gafapi04petaretrospectivestudy
AT xiefang nontumoraluptakeof68gafapi04petaretrospectivestudy
AT huafengchun nontumoraluptakeof68gafapi04petaretrospectivestudy
AT zhaojun nontumoraluptakeof68gafapi04petaretrospectivestudy